BioArctic AB (publ) (STO:BIOA.B)
322.60
+6.80 (2.15%)
Jul 28, 2026, 5:29 PM CET
BioArctic AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,205 | 1,040 | 512.93 | 611.57 | 805.39 | 848.41 |
Short-Term Investments | 829.92 | 1,150 | 265.99 | 500 | - | - |
Cash & Short-Term Investments | 2,035 | 2,190 | 778.92 | 1,112 | 805.39 | 848.41 |
Cash Growth | 158.02% | 181.22% | -29.93% | 38.02% | -5.07% | - |
Accounts Receivable | - | 121.65 | 71.2 | 0.22 | - | 2.84 |
Other Receivables | - | 21.31 | 35.63 | 6.88 | 7.96 | 6.21 |
Total Trade Receivables | - | 142.95 | 106.82 | 7.11 | 7.96 | 9.04 |
Other Current Assets | 561.97 | 153.57 | 124.93 | 34.07 | 7.5 | 4.34 |
Total Current Assets | 2,597 | 2,487 | 1,011 | 1,153 | 820.84 | 861.79 |
Net Property, Plant & Equipment | 77.63 | 82.98 | 96.62 | 31.13 | 35.26 | 33.75 |
Other Long-Term Assets | 5.01 | 5.29 | 4.4 | 2.21 | 2.2 | 2.2 |
Total Assets | 2,679 | 2,575 | 1,112 | 1,186 | 858.31 | 897.73 |
Accounts Payable | - | 23.94 | 50.45 | 29.87 | 21.49 | 11.82 |
Accrued Expenses | 304.96 | 334.06 | 68.34 | 48.85 | 35.11 | 77.44 |
Current Portion of Leases | 15.69 | 15.72 | 13.15 | 2.83 | 8.86 | 8.09 |
Other Current Liabilities | 76.5 | 147.06 | 43.72 | 43.42 | 5.43 | 3.92 |
Total Current Liabilities | 397.15 | 520.78 | 175.66 | 124.97 | 70.88 | 101.27 |
Long-Term Leases | 25.04 | 28.35 | 41.08 | 2.15 | 1.18 | 7.79 |
Other Long-Term Liabilities | 59.02 | 59.02 | - | 12.39 | - | - |
Total Long-Term Liabilities | 84.06 | 87.37 | 41.08 | 14.54 | 1.18 | 7.79 |
Total Liabilities | 481.21 | 608.15 | 216.74 | 139.5 | 72.07 | 109.05 |
Common Stock | - | 1.77 | 1.77 | 1.77 | 1.76 | 1.76 |
Additional Paid-in Capital | - | 613.11 | 587.1 | 580.98 | 566 | 560.02 |
Accumulated Other Comprehensive Income | - | 0.77 | 1 | 0.96 | 0.96 | 0.96 |
Retained Earnings | - | 1,351 | 305.07 | 462.87 | 217.52 | 225.94 |
Shareholders' Equity | 2,198 | 1,967 | 894.94 | 1,047 | 786.24 | 788.68 |
Total Liabilities & Equity | 2,679 | 2,575 | 1,112 | 1,186 | 858.31 | 897.73 |
Total Debt | 40.74 | 44.07 | 54.23 | 4.98 | 10.04 | 15.88 |
Net Cash (Debt) | 1,994 | 2,146 | 724.69 | 1,107 | 795.35 | 832.53 |
Net Cash Growth | 170.33% | 196.18% | -34.51% | 39.13% | -4.47% | - |
Net Cash Per Share | 22.50 | 24.19 | 8.19 | 12.51 | 8.97 | 9.40 |
Book Value | 2,198 | 1,967 | 894.94 | 1,047 | 786.24 | 788.68 |
Book Value Per Share | 24.81 | 22.17 | 10.11 | 11.83 | 8.87 | 8.90 |
Tangible Book Value | 2,198 | 1,967 | 894.94 | 1,047 | 786.24 | 788.68 |
Tangible Book Value Per Share | 24.81 | 22.17 | 10.11 | 11.83 | 8.87 | 8.90 |